Dubious benefits and potential risk of soy phyto-oestrogens

Lancet

Volumn 355, Issue 9206, 2000, Pages 849-

  Sirtori, C R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; PHYTOESTROGEN; SOYBEAN PROTEIN;

CARCINOGENIC ACTIVITY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; LETTER; MUTAGENIC ACTIVITY; PRIORITY JOURNAL; SIDE EFFECT; TERATOGENESIS;

EID: 0034603428     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)72467-3     Document Type: Letter

References (5)

1. J Ginsburg GM Prelevic Lack of significant hormonal effects and controlled trials of phyto-oestrogens Lancet 335 2000 163 164
2. CR Sirtori E Agradi F Conti E Gatti O Mantero Soybean-protein diet in the treatment of type II hyperlipoproteinaemia Lancet i 1977 275 278
3. JW Anderson BM Johnstone ME Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N Engl J Med 333 1995 276 282
4. CR Sirtori E Gianazza C Manzoni MR Lovati PA Murphy Role of isoflavones in the cholesterol reduction by soy proteins in the clinic Am J Clin Nutr 65 1997 166 167
5. PJ Nestel T Yamashita T Sasahara Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women ATVB 17 1997 3392 3398